New Treatment for Donor Sites

• Status: Withdrawn
• Trial end date: 2010-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Primary research questions/Purpose of the Research.

1. Determine the short term (epidermal regeneration, reduction of pain, infections and length of stay) and long term (scarring, long term recovery, and cost of treatment) outcomes of Microbial Nanocellulose (NC) and fine mesh gauze impregnated with hyaluronan and thrombin (HT).

2. Determine if donor site treatment with NC and HT is as safe as the use of Scarlet Red ointment dressing.

b. Describe the importance of the knowledge that you expect to gain from the research.

To find a donor site dressing that has outcomes equal or better than that of scarlet red.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Medical Branch, Galveston
• Treatments: Hyaluronic Acid; Thrombin

Criteria

Inclusion Criteria:

• Ages 0-90 years.

• Any patient admitted to the hospital with burn injury requiring grafting and a donor site.

Exclusion Criteria:

• Patient with severe burn injuries expected to die.